Endosomal Organization of CpG Constructs Correlates with Enhanced Immune Activation
Source abstract
Abstract
This Letter describes how the endosomal organization of immunostimulatory nanoconstructs can tune the in vitro activation of macrophages. Nanoconstructs composed of gold nanoparticles conjugated with unmethylated cytosine-phosphate-guanine (CpG) oligonucleotides have distinct endosomal distributions depending on the surface curvature. Mixed-curvature constructs produce a relatively high percentage of hollow endosomes, where constructs accumulated primarily along the interior edges. These constructs achieved a higher level of toll-like receptor (TLR) 9 activation along with the enhanced secretion of proinflammatory cytokines and chemokines compared to constant-curvature constructs that aggregated mostly in the center of the endosomes. Our results underscore the importance of intraendosomal interactions in regulating immune responses and targeted delivery.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Extracellular vesicles in disease · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. 10.1038/nature1976410.1038/nature19764 ↗
2. 10.1038/nature1067310.1038/nature10673 ↗
3. 10.1038/s41573-018-0006-z10.1038/s41573-018-0006-z ↗
4. 10.1073/pnas.190280511610.1073/pnas.1902805116 ↗
5. 10.1038/382607a010.1038/382607a0 ↗
6. 10.1146/annurev-bioeng-071811-15012410.1146/annurev-bioeng-071811-150124 ↗
7. 10.1021/ar700280410.1021/ar7002804 ↗
8. 10.1073/pnas.091414010710.1073/pnas.0914140107 ↗
9. 10.1016/j.addr.2008.08.00510.1016/j.addr.2008.08.005 ↗
10. 10.1038/nrd261410.1038/nrd2614 ↗
11. 10.1021/nl500844m10.1021/nl500844m ↗
12. 10.1021/acsnano.5b0513810.1021/acsnano.5b05138 ↗
13. 10.1002/anie.20120111410.1002/anie.201201114 ↗
14. 10.1126/science.112555910.1126/science.1125559 ↗
15. 10.1073/pnas.130580411010.1073/pnas.1305804110 ↗
16. 10.1016/j.addr.2019.04.00810.1016/j.addr.2019.04.008 ↗
17. 10.1021/acs.bioconjchem.7b0025210.1021/acs.bioconjchem.7b00252 ↗
18. 10.1021/nn300296p10.1021/nn300296p ↗
19. 10.1021/ja029693510.1021/ja0296935 ↗
20. 10.1021/cr400714j10.1021/cr400714j ↗
21. 10.1039/C4CS00487F10.1039/C4CS00487F ↗
22. 10.1039/C7CS00877E10.1039/C7CS00877E ↗
23. 10.1021/acsnano.7b0552810.1021/acsnano.7b05528 ↗
24. 10.1021/nl061517x10.1021/nl061517x ↗
25. 10.1039/c3nr02129g10.1039/c3nr02129g ↗
26. 10.1002/anie.20120801910.1002/anie.201208019 ↗
27. 10.1038/s41565-020-0643-310.1038/s41565-020-0643-3 ↗
28. 10.1093/intimm/dxh18610.1093/intimm/dxh186 ↗
29. 10.1016/j.cell.2010.01.02210.1016/j.cell.2010.01.022 ↗
30. 10.3389/fimmu.2014.0049110.3389/fimmu.2014.00491 ↗
31. 10.1016/j.immuni.2018.03.01310.1016/j.immuni.2018.03.013 ↗
32. 10.1038/nature1413810.1038/nature14138 ↗
33. 10.1073/pnas.150285011210.1073/pnas.1502850112 ↗
34. 10.1021/acsami.8b0663310.1021/acsami.8b06633 ↗
35. 10.1016/j.celrep.2016.12.07310.1016/j.celrep.2016.12.073 ↗
36. 10.1021/acs.bioconjchem.9b0031610.1021/acs.bioconjchem.9b00316 ↗
37. 10.1021/nn507095310.1021/nn5070953 ↗
38. 10.1016/j.cell.2005.06.04310.1016/j.cell.2005.06.043 ↗
39. 10.1016/j.tcb.2013.12.00210.1016/j.tcb.2013.12.002 ↗
40. 10.1093/emboj/17.21.623010.1093/emboj/17.21.6230 ↗
41. 10.1021/acs.analchem.8b0371510.1021/acs.analchem.8b03715 ↗
42. 10.1021/ja206777k10.1021/ja206777k ↗
43. 10.1016/j.smim.2003.10.00910.1016/j.smim.2003.10.009 ↗
44. 10.1172/JCI6342810.1172/JCI63428 ↗